1 In 3 Covaxin Takers Reported Adverse Events, BHU Study Claims
A one-year follow-up study conducted by researchers at Banaras Hindu University (BHU) has found that nearly one-third of individuals who received Bharat Biotech’s Covaxin reported ‘adverse events of special interest’ (AESI).
The study,…
Read More...
Read More...